Kenya may give the world the first vaccine to protect against gonorrhoea, which causes about 87 million infections annually.
Scientists at the Kenya Medical Research Institute (Kemri) and the University of Oxford, UK, plan to recruit 50 Kenyans, aged between 18 and 25 years into a six-month gonorrhoea vaccine trial.